- JP-listed companies
- ROHTO PHARMACEUTICAL CO.,LTD.
- Income statement
ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】Income statement
Market cap
¥608.6B
P/E ratio
18.2x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 120,292 | 129,146 | 143,822 | 151,774 | 167,016 | 154,599 | 171,742 | 183,582 | 188,327 | 181,287 | 199,646 | 238,664 | 270,840 | 308,625 |
| Cost of revenue | - | - | - | 61,395 | 67,250 | 63,254 | 70,746 | 74,048 | 74,135 | 74,326 | 83,157 | 101,243 | 113,554 | 133,686 |
| Gross profit | - | - | - | 90,379 | 99,766 | 91,344 | 100,996 | 109,533 | 114,192 | 106,960 | 116,488 | 137,421 | 157,285 | 174,939 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 13,159 | 15,683 | 15,451 | 19,087 | 20,812 | 23,085 | 22,990 | 29,349 | 33,959 | 40,048 | 38,939 |
| Operating expenses | - | - | - | 77,440 | 83,543 | 75,893 | 81,962 | 88,812 | 91,154 | 83,736 | 87,139 | 103,461 | 117,237 | 135,999 |
| Income before tax | 13,684 | 14,730 | 17,100 | 14,098 | 15,339 | 15,964 | 18,849 | 18,970 | 22,735 | 23,910 | 29,084 | 35,568 | 42,434 | 40,430 |
| Provision for income taxes | - | - | - | 5,123 | 5,217 | 4,738 | 7,483 | 6,481 | 6,448 | 6,236 | 6,803 | 7,860 | 10,123 | 11,379 |
| Net income | 5,591 | 5,983 | 4,232 | 8,631 | 9,098 | 10,013 | 9,336 | 9,818 | 15,410 | 16,770 | 21,150 | 26,429 | 31,394 | 31,006 |
| Earnings per share | 69.6 | 68.78 | 77.15 | 76.05 | 80.04 | 87.95 | 81.55 | 86 | 135.13 | 146.78 | 184.26 | 115.62 | 135.61 | 136.11 |
| Diluted EPS | 69.31 | 68.49 | 76.82 | 75.73 | 79.7 | 87.57 | 81.2 | 85.66 | 134.71 | 146.36 | 183.73 | 115.29 | 135.21 | 135.44 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | |||||
| Dividend per share | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 28 | 36 | 32 | 27 | 36 |